CHALLENGE
-
A manufacturer who was traditionally a research organization was making the transition to a become a commercialization company.
​
-
The company had limited personnel and economic resources and was looking for a partner to help bring their first commercial product to market.
OUR APPROACH
-
D2 evaluated the distribution options and given the unique specialty characteristics of the product and the significant patient support requirements conducted a full RFP process to identify the best approach.
​
-
This process resulted in the successful selection both a HUB partner and Specialty Pharmacy delivery model.
​
-
D2 then turned its attention to conducting a robust round of payer research — including pricing models and advisory boards — to determine both market access considerations and potential pricing and contracting needs.
OUTCOMES
-
With D2’s assistance, the manufacturer selected an exclusive distribution model. This model enabled patient centric support without limiting access to patients with this rare disease.
​
-
D2’s managed care team provided full MCO coverage and attained virtually 100% market coverage, including largely consistent application of Prior Authorization requirements among many key payers in the market.